Thrombectomy, TOTAL trial, management of STEMI and NSTEMI
Prof. Sanjit S. Jolly explains what we’ve learned about thrombectomy in MI from the TOTAL trial and shares advice for noncardiologists approaching STEMI and NSTEMI.
Prof. Sanjit S. Jolly explains what we’ve learned about thrombectomy in MI from the TOTAL trial and shares advice for noncardiologists approaching STEMI and NSTEMI.
Prof. Francois Caron explains how to approach a patient trying to quit smoking and what we have learned from the latest large-scale RCT about smoking cessation.
Prof. Paul O’Byrne comments on the most recent studies confirming the safety of long-acting ß2-agonists added to inhaled corticosteroids in patients with asthma.
Prof. P.J. Devereaux guides us through managing patients with perioperative myocardial injury and sheds light on the future of preventing peri-op cardiac events.
Prof. Andrew McIvor considers choices among bronchodilators and inhaled corticosteroids in patients with chronic obstructive pulmonary disease.
Prof. Maria Tiboni shares advice on how to achieve a multidisciplinary approach to bariatric surgery, comments on the prevalence of surgery, and describes the ideal candidate.
Prof. P.J. Devereaux describes the major studies focusing on preventing perioperative cardiac events, including CARP, POISE I, and POISE II.
Prof. Andrew McIvor discusses roles of different agents used in patients with chronic obstructive pulmonary disease.
Prof. Maria Tiboni navigates us through various types of bariatric surgery and explains what outcomes may be achieved.
Prof. Devereaux comments on the frequency of cardiac complications following noncardiac surgeries and explains how we can predict the events preoperatively.